SF-36 | SIQR | PSD | SIQR Symptom | SSS | SIQR VAS Pain | WPI |
---|---|---|---|---|---|---|
Physical | 0.68a | 0.40 | 0.56a | 0.42 | 0.53a | 0.34 |
Limitations mental | 0.71a | 0.53 | 0.63b | 0.54 | 0.51 | 0.45 |
Limitations physical | 0.59a | 0.42 | 0.61b | 0.52 | 0.42c | 0.32 |
Energy/fatigue | 0.66b | 0.57 | 0.69 | 0.68 | 0.42 | 0.45 |
Emotional well-being | 0.48a | 0.29 | 0.51a | 0.37 | 0.38b | 0.21 |
Social functioning | 0.72a | 0.55 | 0.69 | 0.64 | 0.51c | 0.43 |
General health | 0.63a | 0.51 | 0.63b | 0.55 | 0.39 | 0.42 |
Pain (total = 321) | 0.78a | 0.56 | 0.73a | 0.55 | 0.74a | 0.48 |
Pain (No FM = 186) | 0.74a | 0.54 | 0.72a | 0.52 | 0.75a | 0.46 |
Pain (FM = 135) | 0.76a | 0.33 | 0.62a | 0.39 | 0.63a | 0.23 |
↵a p < 0.001;
↵b p < 0.01;
↵c p < 0.05. The SF-36 scores have been reversed so that all scores indicate greater severity. Steiger’s Z test was used for significance of the difference between dependent correlations: (1) SIQR vs PSD (col. 2 and 3); (2) SIQR Symptom vs SSS (col. 4 and 5); and (3) WPI vs SIQR VAS pain (col. 6 and 7). PSD: Polysymptomatic Distress Scale; SIQR: Symptom Impact Questionnaire; SF-36: Medical Outcomes Study Short Form-36; SSS: Symptom Severity Score; VAS: visual analog scale; WPI: Widespread Pain Index; FM: fibromyalgia.